Acarbose enhances human colonic butyrate production.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Journal of NutriLife

• Publication date

  1997-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/JN/127.5.717PMID 9164992
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• One‐year Acarbose Treatment Raises Fasting Serum Acetate in Diabetic Patients

  1995cited by this paper
• Multicenter, placebo-controlled trial comparing acarbose (BAY g 5421) with placebo, tolbutamide, and tolbutamide-plus-acarbose in non-insulin-dependent diabetes mellitus.

  1995cited by this paper
• The Efficacy of Acarbose in the Treatment of Patients with NonInsulin-Dependent Diabetes Mellitus: A Multicenter, Controlled Clinical Trial

  1994cited by this paper
• Long-term efficacy and safety of acarbose in the treatment of obese subjects with non-insulin-dependent diabetes mellitus.

  1994cited by this paper
• Reciprocal regulation of alpha-fetoprotein and albumin gene expression by butyrate in human hepatoma cells.

  1994cited by this paper
• Reciprocal regulation of α-fetoprotein and albumin gene expression by butyrate in human hepatoma cells

  1994cited by this paper
• A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.

  1993cited by this paper
• Effects of acarbose on starch hydrolysis

  1992cited by this paper
• Colonic fermentation and markers of colorectal-cancer risk.

  1992cited by this paper
• Cornstarch fermentation by the colonic microbial community yields more butyrate than does cabbage fiber fermentation; cornstarch fermentation rates correlate negatively with methanogenesis.

  1992cited by this paper
• Colonic fermentation of dietary fibre to short chain fatty acids in patients with adenomatous polyps and colonic cancer.

  1991cited by this paper
• Constancy of glucose and starch fermentations by two different human faecal microbial communities.

  1989cited by this paper
• Short chain fatty acid distributions of enema samples from a sigmoidoscopy population: an association of high acetate and low butyrate ratios with adenomatous polyps and colon cancer.

  1988cited by this paper
• The effect of starch malabsorption on fecal short-chain fatty acid excretion in man.

  1988cited by this paper
• Incidence of methanogenic bacteria in a sigmoidoscopy population: an association of methanogenic bacteria and diverticulosis.

  1986cited by this paper
• An improved enzymic method for the determination of native and modified starch

  1985cited by this paper
• Effects of sodium butyrate, a new pharmacological agent, on cells in culture

  1981cited by this paper
• Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man.

  1980cited by this paper
• Rumen epithelial cell proliferation accelerated by rapid increase in intraruminal butyrate.

  1978cited by this paper
• A serum bottle modification of the Hungate technique for cultivating obligate anaerobes.

  1974cited by this paper
• The Stimulatory Effect of Sodium Butyrate and Sodium Propionate on the Development of Rumen Mucosa in the Young Calf

  1959cited by this paper
• Cultural Methods and Some Characteristics of Some of the More Numerous Groups of Bacteria in the Bovine Rumen

  1953cited by this paper

• Alpha-glucosidase inhibitor decreases the risk of colorectal adenoma in the aged with Type 2 diabetes

  2025cites this paper
• When short-chain fatty acids meet type 2 diabetes mellitus: Revealing mechanisms, envisioning therapies.

  2025cites this paper
• Along the microbiota-gut-brain axis: Use of plant polysaccharides to improve mental disorders.

  2024cites this paper
• Butyrate’s (a short-chain fatty acid) microbial synthesis, absorption, and preventive roles against colorectal and lung cancer

  2024cites this paper
• Two weeks of acarbose treatment shows no effect on gut microbiome composition in patients with type 2 diabetes: a randomised, placebo-controlled, double-blind, crossover study

  2024cites this paper
• Acarbose impairs gut Bacteroides growth by targeting intracellular glucosidases

  2024cites this paper
• Acarbose Impairs Gut Bacteroides Growth by Targeting Intracellular GH97 Enzymes

  2024cites this paper
• The effects of macronutrients metabolism on cellular and organismal aging

  2023cites this paper
• Characterizing the Effect of Amylase Inhibitors on Maltodextrin Metabolism by Gut Bacteria Using Fluorescent Glycan Labeling

  2023cites this paper
• α-Glucosidase inhibitors boost gut immunity by inducing IgA responses in Peyer’s patches

  2023cites this paper
• Calorie restriction mimetic drugs could favorably influence gut microbiota leading to lifespan extension

  2023cites this paper
• A Bayesian method for identifying associations between response variables and bacterial community composition

  2022cites this paper
• Extension of the Life Span by Acarbose: Is It Mediated by the Gut Microbiota?

  2022cites this paper
• Anti-Diabetic Intestinal Mechanisms: Foods, Herbs and Western Medicines.

  2022cites this paper
• The Relationships between Gut Microbiota and Diabetes Mellitus, and Treatments for Diabetes Mellitus

  2022cites this paper
• Loss of sucrase-isomaltase function increases acetate levels and improves metabolic health in Greenlandic cohorts

  2022cites this paper
• Loss of sucrase-isomaltase function increases acetate levels and improves metabolic health in Greenlandic cohorts

  2022cites this paper
• Loss of sucrase-isomaltase function increases acetate levels and improves metabolic health in Greenlandic cohorts

  2022cites this paper
• Loss of sucrase-isomaltase function increases acetate levels and improves metabolic health in Greenlandic cohorts

  2022cites this paper
• Loss of sucrase-isomaltase function increases acetate levels and improves metabolic health in Greenlandic cohorts

  2022cites this paper
• Loss of sucrase-isomaltase function increases acetate levels and improves metabolic health in Greenlandic cohorts

  2022cites this paper
• Loss of sucrase-isomaltase function increases acetate levels and improves metabolic health in Greenlandic cohorts

  2022cites this paper
• Recent Updates on Phytoconstituent Alpha-Glucosidase Inhibitors: An Approach towards the Treatment of Type Two Diabetes

  2022cites this paper
• The effect of acarbose on the gut microbiota: an evidence-based review

  2021cites this paper
• One Month of Classic Therapeutic Ketogenic Diet Decreases Short Chain Fatty Acids Production in Epileptic Patients

  2021cites this paper
• Role of Gut Microbiota in Pathogenesis and Treatment of Type 2 Diabetes

  2021cites this paper
• Prebiotics, Probiotics, Synbiotics, Paraprobiotics and Postbiotic Compounds in IBD

  2021cites this paper
• Loss of sucrase-isomaltase function increases acetate levels and improves metabolic health in Greenlandic cohorts.

  2021cites this paper
• Mechanistic basis and preliminary practice of butyric acid and butyrate sodium to mitigate gut inflammatory diseases: a comprehensive review.

  2021cites this paper
• Association between α‐glucosidase inhibitor use and psoriatic disease risk in patients with type 2 diabetes mellitus: A population‐based cohort study

  2021cites this paper
• Aquaporin5-Targeted Treatment for Dry Eye Through Bioactive Compounds and Gut Microbiota

  2021cites this paper
• Habitual Dietary Intake Affects the Altered Pattern of Gut Microbiome by Acarbose in Patients with Type 2 Diabetes

  2021cites this paper
• Rapid and Accurate Simultaneous Determination of Seven Short-Chain Fatty Acids in Feces by Gas Chromatography – Mass Spectrometry (GC-MS): Application in Type 2 Diabetic Rats and Drug Therapy

  2020cites this paper
• Diabetes medications as potential calorie restriction mimetics—a focus on the alpha-glucosidase inhibitor acarbose

  2020cites this paper
• Modulation of Gut Microbiota Profile and Short-Chain Fatty Acids of Rats Fed with Taro Flour or Taro Starch

  2020cites this paper
• Muribaculaceae Genomes Assembled from Metagenomes Suggest Genetic Drivers of Differential Response to Acarbose Treatment in Mice

  2020cites this paper
• Starch Digestion by Gut Bacteria: Crowdsourcing for Carbs.

  2020cites this paper
• Impact of Gut Dysbiosis on Neurohormonal Pathways in Chronic Kidney Disease

  2019cites this paper
• Nondigestible carbohydrates, butyrate, and butyrate-producing bacteria

  2019cites this paper
• The Glucoamylase Inhibitor Acarbose Has a Diet-Dependent and Reversible Effect on the Murine Gut Microbiome

  2019cites this paper
• A polysaccharide extracted from Astragalus membranaceus residue improves cognitive dysfunction by altering gut microbiota in diabetic mice.

  2019cites this paper
• Impacts of dietary silver nanoparticles and probiotic administration on the microbiota of an in-vitro gut model.

  2019cites this paper
• Changes in the gut microbiome and fermentation products concurrent with enhanced longevity in acarbose-treated mice

  2019influential citation
• Treatment: Alpha Glucosidase Inhibitors

  2019cites this paper
• The Relationship between Frequently Used Glucose-Lowering Agents and Gut Microbiota in Type 2 Diabetes Mellitus

  2018cites this paper
• Phenylketonuric diet negatively impacts on butyrate production.

  2018cites this paper
• Sex-dependent Differences in Liver and Gut Metabolomic Profiles With Acarbose and Calorie Restriction in C57BL/6 Mice

  2018cites this paper
• The influence of diabetes and antidiabetic medications on the risk of pancreatic cancer: a nationwide population-based study in Korea

  2018cites this paper
• Comparisons of Effects on Intestinal Short-Chain Fatty Acid Concentration after Exposure of Two Glycosidase Inhibitors in Mice.

  2018cites this paper
• Effect of dietary fat to starch content on fecal microbiota composition and activity in dogs.

  2018cites this paper
• Changes in the gut microbiota and fermentation products associated with enhanced longevity in acarbose-treated mice

  2018influential citation
• Diet, Microbiota, and Metabolic Health: Trade-Off Between Saccharolytic and Proteolytic Fermentation.

  2018cites this paper
• Effect of miglitol on the suppression of nonalcoholic steatohepatitis development and improvement of the gut environment in a rodent model

  2017cites this paper
• Effects of Antidiabetic Drugs on Gut Microbiota Composition

  2017cites this paper
• Rett Syndrome: A Focus on Gut Microbiota

  2017cites this paper
• Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests

  2017cites this paper
• Effects of Acarbose on the Gut Microbiota of Prediabetic Patients: A Randomized, Double-blind, Controlled Crossover Trial

  2017cites this paper
• Diets containing different fermentable substrates can affect mucosal and systemic immune parameters in rats under homeostatic conditions

  2016cites this paper
• Kiwifruit fibre level influences the predicted production and absorption of SCFA in the hindgut of growing pigs using a combined in vivo-in vitro digestion methodology.

  2016cites this paper
• Targeting glucose metabolism for healthy aging

  2016influential citation
• The effects of short-chain fatty acids on the cardiovascular system

  2016cites this paper
• Ecophysiology of novel intestinal butyrate-producing bacteria

  2016cites this paper
• Sex differences in gut fermentation and immune parameters in rats fed an oligofructose-supplemented diet

  2015cites this paper
• Use of an α-Glucosidase Inhibitor and the Risk of Colorectal Cancer in Patients With Diabetes: A Nationwide, Population-Based Cohort Study

  2015cites this paper
• Effects of dietary fermentable material on innate and adaptive immune measures in male and female rats under resting and immunized conditions

  2015cites this paper
• Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes

  2015cites this paper
• GAMMA RADIATION: EFFECT ON TOTAL AND RESISTANT STARCH AND IN VITRO DIGESTIBILITY OF STARCH AND PROTEIN IN SELECTED FOODS

  2014cites this paper
• Type II Diabetes, Metformin Use, and Colorectal Neoplasia: Mechanisms of Action and Implications for Future Research

  2014cites this paper
• Temporal change in the gut community of rats fed high amylose cornstarch is driven by endogenous urea rather than strictly on carbohydrate availability

  2013cites this paper
• Effect of the prebiotics nutriose FB 06 and raftilose P95 upon the uptake of the short-chain fatty acid butyrate and upon its effect on cell proliferation, viability and differentiation in IEC-6 cells

  2012cites this paper
• Antioxidative capacity of rosehip polyphenols and their potential role in type 2 diabetes mellitus prevention and management

  2012cites this paper
• The Microbe-Derived Short Chain Fatty Acid Butyrate Targets miRNA-Dependent p21 Gene Expression in Human Colon Cancer

  2011cites this paper
• The short-chain fatty acid butyrate is a substrate of breast cancer resistance protein.

  2011cites this paper
• breast cancer resistance protein The short-chain fatty acid butyrate is a substrate of

  2011cites this paper
• Dietary fructooligosaccharides and wheat bran elicit specific and dose-dependent gene expression profiles in the proximal colon epithelia of healthy Fischer 344 rats.

  2011cites this paper
• Continuous feeding of antimicrobial growth promoters to commercial swine during the growing/finishing phase does not modify faecal community erythromycin resistance or community structure

  2011cites this paper
• Natural products as alpha-amylase and alpha-glucosidase inhibitors and their hypoglycaemic potential in the treatment of diabetes: an update.

  2010cites this paper
• Free fatty acid receptors and their physiological roles in the colon.

  2010cites this paper
• From the gut to the peripheral tissues: the multiple effects of butyrate

  2010cites this paper
• Short chain fatty acids and colonic health

  2009cites this paper
• Changes in human faecal microbiota due to chemotherapy analyzed by TaqMan-PCR and PCR-DGGE

  2009cites this paper
• Microbial Production of Bioactive Metabolites

  2009cites this paper
• The nutraceutical role of the Phaseolus vulgaris α-amylase inhibitor

  2008cites this paper
• Butyrate ingestion improves hepatic glycogen storage in the re-fed rat

  2008cites this paper
• Health Benefits of Traditional Corn, Beans, and Pumpkin: In Vitro Studies for Hyperglycemia and Hypertension Management

  2007cites this paper
• Low‐dose acarbose does not delay digestion of starch but reduces its bioavailability

  2007cites this paper
• Review article: the role of butyrate on colonic function

  2007cites this paper
• Decrease in oxidative phosphorylation yield in presence of butyrate in perfused liver isolated from fed rats

  2007cites this paper
• EVALUATION OF PEPPER (CAPSICUM ANNUUM) FOR MANAGEMENT OF DIABETES AND HYPERTENSION

  2007cites this paper
• Pinto bean consumption changes SCFA profiles in fecal fermentations, bacterial populations of the lower bowel, and lipid profiles in blood of humans.

  2007cites this paper
• Ökologie des Darmes

  2006cites this paper
• Dietary fructooligosaccharides alter the cultivable faecal population of rats but do not stimulate the growth of intestinal bifidobacteria.

  2006cites this paper
• Colonic Health: Fermentation and Short Chain Fatty Acids

  2006cites this paper
• Acarbose treatment lowers generation and serum concentrations of the protein-bound solute p-cresol: a pilot study.

  2006cites this paper
• Establishing evidence for practice in medical nutrition therapy: a case study of the impact of a high amylose resistant starch diet on clinical indicators of the insulin resistant syndrome

  2005cites this paper
• Evaluation of the pulsed discharge helium ionization detector for the analysis of hydrogen and methane in breath.

  2004cites this paper
• Starch digestion, large-bowel fermentation and intestinal mucosal cell proliferation in rats treated with the α-glucosidase inhibitor acarbose

  2004cites this paper
• Folate derived from cecal bacterial fermentation does not increase liver folate stores in 28-d folate-depleted male Sprague-Dawley rats.

  2003cites this paper
• Review of acarbose therapeutic strategies in the long-term treatment and in the prevention of type 2 diabetes.

  2003cites this paper
• Influences of dietary adaptation and source of resistant starch on short-chain fatty acids in the hindgut of rats

  2003cites this paper